The opportunistic pathogen Pseudomonas aeruginosa produces two major cell surface lipopolysaccharides, characterized by distinct O antigens, called common polysaccharide antigen (CPA) and O-specific antigen (OSA). CPA contains a polymer of Drhamnose (D-Rha) in ␣1-2 and ␣1-3 linkages. Three putative glycosyltransferase genes, wbpX, wbpY, and wbpZ, are part of the CPA biosynthesis cluster. To characterize the enzymatic function of the wbpZ gene product, we chemically synthesized the donor substrate GDP-D-Rha and enzymatically synthesized GDP-D-[ 3 H]Rha. Using nuclear magnetic resonance (NMR) spectroscopy, we showed that WbpZ transferred one D-Rha residue from GDP-D-Rha in ␣1-3 linkage to both GlcNAc-and GalNAcdiphosphate-lipid acceptor substrates. WbpZ is also capable of transferring D-mannose (D-Man) to these acceptors. Therefore, WbpZ has a relaxed specificity with respect to both acceptor and donor substrates. The diphosphate group of the acceptor, however, is required for activity. WbpZ does not require divalent metal ion for activity and exhibits an unusually high pH optimum of 9. WbpZ from PAO1 is therefore a GDP-D-Rha:GlcNAc/GalNAc-diphosphate-lipid ␣1,3-D-rhamnosyltransferase that has significant activity of GDP-D-Man:GlcNAc/GalNAc-diphosphate-lipid ␣1,3-D-mannosyltransferase. We used site-directed mutagenesis to replace the Asp residues of the two DXD motifs with Ala. Neither of the mutant constructs of wbpZ (D172A or D254A) could be used to rescue CPA biosynthesis in the ⌬wbpZ knockout mutant in a complementation assay. This suggested that D172 and D254 are essential for WbpZ function. This work is the first detailed characterization study of a D-Rha-transferase and a critical step in the development of CPA synthesis inhibitors.
IMPORTANCEThis is the first characterization of a D-rhamnosyltransferase and shows that it is essential in Pseudomonas aeruginosa for the synthesis of the common polysaccharide antigen. P seudomonas aeruginosa is a Gram-negative bacterium that is ubiquitous in the environment and is an opportunistic pathogen that can cause life-threatening infections in humans whose defenses are compromised, e.g., those with immune deficiency, burn wounds, cancer, or cystic fibrosis (CF). Specific epidemic strains have been shown to cause local outbreaks and hospital-associated infections (1). In the airways of CF patients, P. aeruginosa thrives, adopting a biofilm lifestyle, and often becomes resistant to antibiotic treatment. Therefore, it is important to understand the mechanisms by which P. aeruginosa synthesizes its virulence factor, in order to develop new antibacterial strategies.Lipopolysaccharides (LPS) on the outer membrane of P. aeruginosa are required for its survival against host defense mechanisms; hence, LPS is one of the major virulence factors (2-4). These bacteria are unusual in that they simultaneously synthesize two distinct forms of LPS differing in the O-antigen structures (5). Each of these O antigens is synthesized by a different pathway.